Kevin Ronald Rosi, MD
Psychiatry · Sacramento
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 15
- 2 carriers
- Office
- 1
- Since medical school
- 24 years
- Graduated 2002
Offices
1 location · Mindful Health Solutions A Professional Medical Corporation · 55 clinicians in this group
Looking this up.
Plans that list them
15 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Rosi’s office at (916) 932-0380 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
15 of 15 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence A91407 · Current
Licensed to practise in California · since 2005 · expires 2027-01-31 · St. George'S University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$87,277
Medicare paid this office $87,277 for 33 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Treatment using magnetic field to stimulate nerve cells in brain, subsequent delivery and management | 13 | $28,182 | $101 |
| Return visit (30+ min) | 16 | $6,061 | $101 |
| Short return visit (20+ min) | 12 | $2,347 | $73 |
| Treatment using magnetic field to stimulate nerve cells in brain, initial delivery and management | 12 | $2,184 | $182 |
Who their Medicare patients are
33 Original Medicare patients in 2024. Average age 65 · 85 and older 0% · Health risk score 1.15. At or below the middle of the specialty; the typical psychiatry clinician is at 1.35.
Conditions among them: Depression 75% · High blood pressure 45%.
The office billed $446,721, Medicare allowed $111,174 and paid $87,277; for 463 services of 10 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 33 | 463 | 65 | 1.15 | $446,721 | $87,277 |
| 2023 | 21 | 507 | 61 | 0.88 | $481,249 | $83,119 |
| 2022 | 31 | 435 | 60 | 1.04 | $436,050 | $76,310 |
| 2021 | 38 | 466 | 62 | 0.99 | $369,334 | $81,136 |
| 2020 | 21 | 602 | 60 | 0.90 | $241,727 | $37,816 |
| 2019 | 24 | 414 | 58 | 0.85 | $200,593 | $31,831 |
| 2018 | 20 | 395 | 55 | 0.92 | $166,974 | $28,366 |
| 2017 | 11 | 222 | 58 | 0.89 | $116,733 | $18,960 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 1 service
| Return visit (30+ min) | 16 | $7,542 | $101 |
2022: 2 services
| Return visit (30+ min) | 26 | $6,297 | $77 |
| Psychotherapy with evaluation and management visit, 30 minutes | 17 | $1,738 | $47 |
2021: 3 services
| Return visit (30+ min) | 33 | $10,926 | $77 |
| Psychotherapy with evaluation and management visit, 30 minutes | 29 | $5,071 | $50 |
| Assessment of emotional or behavioral problems | 14 | $200 | $4 |
2020: 4 services
| Return visit (30+ min) | 19 | $5,971 | $68 |
| Psychotherapy with evaluation and management visit, 30 minutes | 19 | $5,458 | $53 |
| Short return visit (20+ min) | 11 | $2,122 | $48 |
| Assessment of emotional or behavioral problems | 17 | $528 | $4 |
2019: 4 services
| Treatment using magnetic field to stimulate nerve cells in brain, subsequent delivery and management | 11 | $19,846 | $92 |
| Return visit (30+ min) | 16 | $4,180 | $77 |
| Psychotherapy with evaluation and management visit, 30 minutes | 15 | $3,416 | $55 |
| Short return visit (20+ min) | 13 | $2,825 | $59 |
2018: 3 services
| Psychotherapy with evaluation and management visit, 30 minutes | 16 | $3,479 | $48 |
| Return visit (30+ min) | 14 | $3,329 | $71 |
| Short return visit (20+ min) | 18 | $3,047 | $48 |
Drugs they prescribed that Part D paid
$29,277
Pharmacies billed $29,277 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 259) in 2024. At or below the middle of the specialty; the typical psychiatry clinician is at 0%.
237 generic and 22 brand-name prescriptions · $29,277 in drug cost · 18 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Lisdexamfetamine Dimesylate | 13 | $3,217 | $247 |
| Duloxetine | 13 | $581 | $45 |
| Bupropion Xl | 21 | $421 | $20 |
| Buspirone | 15 | $374 | $25 |
| Trazodone | 19 | $317 | $17 |
See all 11 drugs
| Lisdexamfetamine Dimesylate | 13 | $3,217 | $247 |
| Duloxetine | 13 | $581 | $45 |
| Bupropion Xl | 21 | $421 | $20 |
| Buspirone | 15 | $374 | $25 |
| Trazodone | 19 | $317 | $17 |
| Venlafaxine Hcl Er | 20 | $270 | $14 |
| Quetiapine | 11 | $253 | $23 |
| Lurasidone | 16 | $249 | $16 |
| Lamotrigine | 14 | $202 | $14 |
| Clonazepam | 18 | $114 | $6 |
| Alprazolam | 17 | $32 | $2 |
Year by year
| 2024 | 259 | 28 | 0% (0) | 8% | $29,277 |
| 2023 | 334 | 26 | 0% (0) | 18% | $77,294 |
| 2022 | 480 | 36 | 0% (0) | 11% | $109,449 |
| 2021 | 518 | 37 | 0% (0) | 7% | $109,883 |
| 2020 | 450 | 32 | 0% (0) | 9% | $90,545 |
| 2019 | 398 | 25 | 0% (0) | 6% | $67,323 |
| 2018 | 401 | 35 | 0% (0) | 4% | $34,048 |
| 2017 | 204 | 20 | 0% (0) | 6% | $12,294 |
| 2016 | 111 | None | 0% (0) | None | $8,540 |
| 2015 | 53 | 20 | 0% (0) | None | $9,781 |
| 2014 | 86 | 22 | 0% (0) | 14% | $17,550 |
| 2013 | 48 | 11 | 0% (0) | None | $1,393 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 11 drugs
| Spravato | 41 | $47,702 | $1,163 |
| Lurasidone | 13 | $13,106 | $1,008 |
| Trintellix | 13 | $6,439 | $495 |
| Bupropion Xl | 18 | $506 | $28 |
| Duloxetine | 27 | $459 | $17 |
| Methylphenidate | 12 | $241 | $20 |
| Quetiapine | 18 | $230 | $13 |
| Aripiprazole | 15 | $191 | $13 |
| Clonazepam | 17 | $177 | $10 |
| Zolpidem | 26 | $71 | $3 |
| Alprazolam | 16 | $26 | $2 |
2022: 17 drugs
| Spravato | 26 | $26,462 | $1,018 |
| Bupropion Xl | 55 | $1,474 | $27 |
| Gabapentin | 24 | $611 | $25 |
| Propranolol | 16 | $493 | $31 |
| Sertraline | 27 | $478 | $18 |
| Bupropion Hcl Sr | 19 | $380 | $20 |
| Duloxetine | 31 | $323 | $10 |
| Clonazepam | 26 | $297 | $11 |
| Escitalopram | 11 | $274 | $25 |
| Methylphenidate | 11 | $253 | $23 |
| Zolpidem | 38 | $240 | $6 |
| Lamotrigine | 15 | $186 | $12 |
| Quetiapine | 22 | $179 | $8 |
| Clonidine | 13 | $165 | $13 |
| Lorazepam | 12 | $126 | $10 |
| Alprazolam | 13 | $74 | $6 |
| Trazodone | 11 | $41 | $4 |
2021: 21 drugs
| Latuda | 12 | $17,268 | $1,439 |
| Modafinil | 11 | $9,651 | $877 |
| Belsomra | 11 | $4,465 | $406 |
| Aripiprazole | 13 | $1,758 | $135 |
| Bupropion Xl | 54 | $1,378 | $26 |
| Gabapentin | 33 | $1,232 | $37 |
| Lithium Carbonate Er | 25 | $556 | $22 |
| Duloxetine | 25 | $483 | $19 |
| Mirtazapine | 18 | $481 | $27 |
| Propranolol | 18 | $456 | $25 |
| Sertraline | 45 | $437 | $10 |
| Escitalopram | 19 | $405 | $21 |
| Alprazolam | 17 | $350 | $21 |
| Clonazepam | 36 | $319 | $9 |
| Lamotrigine | 22 | $201 | $9 |
| Lithium Carbonate | 17 | $172 | $10 |
| Paroxetine | 11 | $82 | $7 |
| Lorazepam | 13 | $76 | $6 |
| Clonidine | 14 | $64 | $5 |
| Quetiapine | 11 | $62 | $6 |
| Zolpidem | 13 | $36 | $3 |
2020: 16 drugs
| Latuda | 12 | $20,275 | $1,690 |
| Belsomra | 11 | $4,083 | $371 |
| Tranylcypromine Sulfate | 11 | $1,514 | $138 |
| Amitriptyline | 19 | $1,076 | $57 |
| Bupropion Xl | 33 | $994 | $30 |
| Gabapentin | 43 | $913 | $21 |
| Lithium Carbonate Er | 31 | $587 | $19 |
| Clonazepam | 36 | $427 | $12 |
| Duloxetine | 28 | $337 | $12 |
| Propranolol | 19 | $314 | $17 |
| Mirtazapine | 17 | $274 | $16 |
| Alprazolam | 13 | $218 | $17 |
| Sertraline | 35 | $207 | $6 |
| Escitalopram | 12 | $146 | $12 |
| Lithium Carbonate | 12 | $127 | $11 |
| Lamotrigine | 16 | $114 | $7 |
2019: 12 drugs
| Tranylcypromine Sulfate | 12 | $2,408 | $201 |
| Bupropion Xl | 37 | $1,051 | $28 |
| Gabapentin | 47 | $983 | $21 |
| Amitriptyline | 15 | $708 | $47 |
| Lithium Carbonate Er | 16 | $594 | $37 |
| Propranolol | 14 | $459 | $33 |
| Clonazepam | 37 | $323 | $9 |
| Escitalopram | 27 | $317 | $12 |
| Sertraline | 39 | $264 | $7 |
| Quetiapine | 12 | $217 | $18 |
| Lorazepam | 11 | $124 | $11 |
| Alprazolam | 12 | $107 | $9 |
2018: 12 drugs
| Bupropion Xl | 47 | $1,182 | $25 |
| Desvenlafaxine Succinate Er | 11 | $630 | $57 |
| Gabapentin | 24 | $497 | $21 |
| Lithium Carbonate Er | 22 | $333 | $15 |
| Quetiapine | 13 | $221 | $17 |
| Mirtazapine | 12 | $124 | $10 |
| Hydroxyzine Pamoate | 16 | $93 | $6 |
| Clonazepam | 31 | $92 | $3 |
| Escitalopram | 15 | $88 | $6 |
| Sertraline | 33 | $69 | $2 |
| Lorazepam | 13 | $50 | $4 |
| Lamotrigine | 12 | $33 | $3 |
2017: 6 drugs
| Olanzapine | 17 | $3,391 | $199 |
| Bupropion Xl | 35 | $760 | $22 |
| Fluoxetine | 13 | $250 | $19 |
| Mirtazapine | 24 | $178 | $7 |
| Sertraline | 17 | $116 | $7 |
| Clonazepam | 27 | $95 | $4 |
2016: 4 drugs
| Duloxetine | 14 | $472 | $34 |
| Bupropion Xl | 12 | $283 | $24 |
| Mirtazapine | 18 | $160 | $9 |
| Clonazepam | 12 | $26 | $2 |
2013: 1 drug
| Risperidone | 11 | $239 | $22 |
Money from drug and device companies
$792 in 2025
| 2025 | 10 | 33 | None | $792 |
| 2024 | 5 | 6 | None | $174 |
| 2019 | 1 | 1 | None | $18 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbvie | Vraylar | $209 | 9 payments
|
| Janssen Pharmaceuticals | Spravato | $119 | 4 payments
|
| Bausch Health US | Aplenzin | $115 | 5 payments
|
| Otsuka America Pharmaceutical | Rexulti | $104 | 4 payments
|
| Axsome Therapeutics | Auvelity | $82 | 3 payments
|
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Caplyta | $47 | 2 payments
|
See all 33 published payments
| Janssen Pharmaceuticals | Meals · 2025-12-15 | Spravato | $29 |
| Neurocrine BioSciences | Meals · 2025-12-09 | Ingrezza | $28 |
| Bausch Health US | Meals · 2025-11-18 | Aplenzin | $24 |
| Otsuka America Pharmaceutical | Meals · 2025-11-17 | Rexulti | $31 |
| Abbvie | Meals · 2025-11-12 | Vraylar | $19 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-10-31 | Trintellix | $14 |
| Axsome Therapeutics | Meals · 2025-10-30 | Auvelity | $31 |
| Bausch Health US | Meals · 2025-10-30 | Aplenzin | $17 |
| Janssen Pharmaceuticals | Meals · 2025-10-23 | Spravato | $32 |
| Janssen Pharmaceuticals | Meals · 2025-10-01 | Spravato | $33 |
| Abbvie | Meals · 2025-09-25 | Vraylar | $25 |
| Supernus Pharmaceuticals | Meals · 2025-08-28 | Qelbree | $21 |
| Otsuka America Pharmaceutical | Meals · 2025-08-25 | Rexulti | $25 |
| Bausch Health US | Meals · 2025-08-18 | Aplenzin | $25 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-08-12 | Trintellix | $14 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-07-20 | Caplyta | $20 |
| Axsome Therapeutics | Meals · 2025-07-09 | Auvelity | $30 |
| Otsuka America Pharmaceutical | Meals · 2025-06-11 | Rexulti | $27 |
| Abbvie | Meals · 2025-06-09 | Vraylar | $27 |
| Bausch Health US | Meals · 2025-06-02 | Aplenzin | $21 |
| Abbvie | Meals · 2025-05-20 | Vraylar | $29 |
| Abbvie | Meals · 2025-05-07 | Vraylar | $22 |
| Axsome Therapeutics | Meals · 2025-05-03 | Auvelity | $22 |
| Bausch Health US | Meals · 2025-04-22 | Aplenzin | $27 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-04-22 | Caplyta | $27 |
| Abbvie | Meals · 2025-04-12 | Vraylar | $25 |
| Janssen Pharmaceuticals | Meals · 2025-03-10 | Spravato | $26 |
| Abbvie | Meals · 2025-03-05 | Vraylar | $18 |
| Neurocrine BioSciences | Meals · 2025-02-25 | Ingrezza | $16 |
| Otsuka America Pharmaceutical | Meals · 2025-02-19 | Rexulti | $20 |
| Abbvie | Meals · 2025-02-06 | Vraylar | $22 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-02-04 | Cobenfy | $23 |
| Abbvie | Meals · 2025-01-13 | Vraylar | $22 |
See earlier years (2024, 2019)
2024: $174
| Janssen Pharmaceuticals | Spravato | $80 | 2 payments
|
| Indivior | Perseris | $38 | 1 payment
|
| Abbvie | Vraylar | $22 | 1 payment
|
| Takeda Pharmaceuticals U.S.A. | Trintellix | $17 | 1 payment
|
| Almatica Pharma | Loreev Xr | $17 | 1 payment
|
2019: $18
| Janssen Pharmaceuticals | Spravato | $18 | 1 payment
|
Professional record
- NPI
- 1821150954
- Licence
- CA A91407California A91407: Current · expires 2027-01-31
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 2084P0804X (2084P0804X)
- Mailing address
- 203 Durand Way, Palo Alto, CA, 94304
- NPI first listed
- 2006-12-14
- NPI last updated
- 2007-07-08
This is when the NPI record was last certified, not a medical board exam.